Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3706776)

Published in Stem Cell Res Ther on January 24, 2013

Authors

Janna V Serbo, Sharon Gerecht

Articles cited by this

Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42

Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00

Molecular mechanisms and clinical applications of angiogenesis. Nature (2011) 13.36

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood (2006) 8.56

Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73

Tissue-engineered lungs for in vivo implantation. Science (2010) 5.90

PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21

Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85

Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells (2004) 4.79

Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66

Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res (2003) 3.53

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells (2009) 3.46

Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19

Deaths: final data for 2009. Natl Vital Stat Rep (2011) 3.18

Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15

Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity (2004) 2.89

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res (2007) 2.74

Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol (2007) 2.65

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood (2007) 2.64

Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol (2010) 2.54

Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials (2009) 2.41

Readily available tissue-engineered vascular grafts. Sci Transl Med (2011) 2.13

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12

Organ engineering based on decellularized matrix scaffolds. Trends Mol Med (2011) 2.07

Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat Biotechnol (2011) 2.01

Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A (2010) 1.97

Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood (2011) 1.91

Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Res C Embryo Today (2007) 1.84

Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol (2007) 1.63

Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res (2002) 1.63

VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol (2009) 1.57

Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol (2004) 1.51

VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood (2011) 1.46

Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc Natl Acad Sci U S A (2011) 1.45

Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol (2009) 1.42

Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene (2008) 1.39

Hematoendothelial differentiation of human embryonic stem cells. Curr Protoc Cell Biol (2007) 1.39

Engineering vessel-like networks within multicellular fibrin-based constructs. Biomaterials (2011) 1.28

Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest (2003) 1.28

Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood (2003) 1.25

Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci U S A (2011) 1.24

In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab Chip (2011) 1.24

Distinct ECM mechanosensing pathways regulate microtubule dynamics to control endothelial cell branching morphogenesis. J Cell Biol (2011) 1.24

Tissue engineering of blood vessel. J Cell Mol Med (2007) 1.20

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol (2009) 1.17

The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials (2010) 1.16

Tissue-engineered blood vessels: alternative to autologous grafts? Arterioscler Thromb Vasc Biol (2005) 1.16

Strategies for tissue and organ decellularization. J Cell Biochem (2012) 1.15

The effect of physical exercise on endothelial function. Sports Med (2009) 1.15

Endothelial cell adhesion, signaling, and morphogenesis in fibroblast-derived matrix. Matrix Biol (2009) 1.14

Role of shear stress and stretch in vascular mechanobiology. J R Soc Interface (2011) 1.07

Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials (2010) 1.02

Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev Dyn (2005) 0.99

3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release (2010) 0.96

Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres. PLoS One (2012) 0.96

Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A (2011) 0.95

Functional groups affect physical and biological properties of dextran-based hydrogels. J Biomed Mater Res A (2010) 0.95

Blood vessels engineered from human cells. Trends Cardiovasc Med (2006) 0.92

The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan. Biomaterials (2011) 0.92

Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev (2012) 0.91

Bioengineering in organ transplantation: targeting the liver. Transplant Proc (2011) 0.89

Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression. Circulation (2009) 0.87

Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells. Tissue Eng Part A (2011) 0.85

Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective. Br J Clin Pharmacol (2013) 0.84

Vascularization shaping the heart. Ann N Y Acad Sci (2010) 0.81

Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. Yale J Biol Med (2012) 0.80

Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Acta Pharmacol Sin (2009) 0.78

The development of the vasculature and its extracellular matrix: a gradual process defined by sequential cellular and matrix remodeling events. Am J Physiol Heart Circ Physiol (2010) 0.77

Articles by these authors

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12

Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood (2011) 1.91

Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 1.86

Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials (2007) 1.72

Micro-bioreactor array for controlling cellular microenvironments. Lab Chip (2007) 1.52

Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp Cell Res (2009) 1.49

A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33

Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci U S A (2011) 1.24

Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells. J Cell Mol Med (2010) 1.24

Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc Natl Acad Sci U S A (2013) 1.18

Enhancement of In Vitro Capillary Tube Formation by Substrate Nanotopography. Adv Mater (2008) 1.16

Practical aspects of cardiac tissue engineering with electrical stimulation. Methods Mol Med (2007) 1.11

Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells. Am J Physiol Cell Physiol (2010) 1.10

The differential formation of the LINC-mediated perinuclear actin cap in pluripotent and somatic cells. PLoS One (2012) 1.09

Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev (2010) 1.07

Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc Res (2012) 1.05

Unforeseen decreases in dissolved oxygen levels affect tube formation kinetics in collagen gels. Am J Physiol Cell Physiol (2011) 1.05

Differences in the microrheology of human embryonic stem cells and human induced pluripotent stem cells. Biophys J (2010) 1.04

Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels. Biomaterials (2012) 1.02

Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials (2010) 1.02

Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res (2013) 1.02

Reconstructing the differentiation niche of embryonic stem cells using biomaterials. Macromol Biosci (2010) 0.97

The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J (2012) 0.95

Functional groups affect physical and biological properties of dextran-based hydrogels. J Biomed Mater Res A (2010) 0.95

Breast cancer cell-derived matrix supports vascular morphogenesis. Am J Physiol Cell Physiol (2012) 0.94

Endothelial cell responses to micropillar substrates of varying dimensions and stiffness. J Biomed Mater Res A (2012) 0.94

Low oxygen tension enhances endothelial fate of human pluripotent stem cells. Arterioscler Thromb Vasc Biol (2014) 0.94

Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther (2010) 0.93

Design and development of microbioreactors for long-term cell culture in controlled oxygen microenvironments. Biomed Microdevices (2012) 0.92

Perivascular cells in blood vessel regeneration. Biotechnol J (2013) 0.91

Hyaluronic Acid hydrogels support cord-like structures from endothelial colony-forming cells. Tissue Eng Part A (2011) 0.89

Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid. Biomaterials (2010) 0.88

Patterning microscale extracellular matrices to study endothelial and cancer cell interactions in vitro. Lab Chip (2012) 0.87

Engineering approaches for investigating tumor angiogenesis: exploiting the role of the extracellular matrix. Cancer Res (2012) 0.87

Engineered microenvironments for human stem cells. Birth Defects Res C Embryo Today (2008) 0.87

Characterizing human pluripotent-stem-cell-derived vascular cells for tissue engineering applications. Stem Cells Dev (2014) 0.87

Integration and regression of implanted engineered human vascular networks during deep wound healing. Stem Cells Transl Med (2013) 0.85

Microbioreactors to manipulate oxygen tension and shear stress in the microenvironment of vascular stem and progenitor cells. Biotechnol Appl Biochem (2012) 0.84

Vascular engineering using human embryonic stem cells. Biotechnol Prog (2009) 0.84

A novel in vitro model for microvasculature reveals regulation of circumferential ECM organization by curvature. PLoS One (2013) 0.82

Acellular implantable and injectable hydrogels for vascular regeneration. Biomed Mater (2015) 0.82

Preview. Mending the failing heart with a vascularized cardiac patch. Cell Stem Cell (2009) 0.82

Vascular regeneration: engineering the stem cell microenvironment. Regen Med (2009) 0.81

Derivation and network formation of vascular cells from human pluripotent stem cells. Methods Mol Biol (2014) 0.80

Micropatterned surfaces to study hyaluronic acid interactions with cancer cells. J Vis Exp (2010) 0.80

Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013. Ann Biomed Eng (2013) 0.79

Recent progress in the use of induced pluripotent stem cells in vascular regeneration. Expert Rev Cardiovasc Ther (2013) 0.78

Development of a biodegradable, temperature-sensitive dextran-based polymer as a cell-detaching substrate. Macromol Biosci (2011) 0.77

The design of dextran-based hypoxia-inducible hydrogels via in situ oxygen-consuming reaction. Macromol Rapid Commun (2014) 0.77

Derivation of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells. Methods Mol Biol (2016) 0.76

Endothelial progenitor cell recruitment in a microfluidic vascular model. Biofabrication (2015) 0.76

Research highlights. Regen Med (2011) 0.75

Fast and furious: the mass and motion of stem cells. Biophys J (2013) 0.75

Defining Differences among Perivascular Cells Derived from Human Pluripotent Stem Cells. Stem Cell Reports (2014) 0.75

Diffusing Colloidal Probes of kT-Scale Biomaterial-Cell Interactions. Langmuir (2016) 0.75